Minimizing out-of-pocket prescription drug costs for Medicare beneficiaries: not just 'a drop in the bucket'

J Am Pharm Assoc (2003). 2014 Nov-Dec;54(6):604-9. doi: 10.1331/JAPhA.2014.14043.

Abstract

Objective: To identify the frequency of uptake and financial impact of four cost-minimization strategies used to assist Medicare beneficiaries in lowering their out-of-pocket (OOP) costs.

Design: Cost-savings analysis.

Setting: Twelve outreach events were conducted in six different cities throughout Northern and Central California during the 2013 Medicare open enrollment period.

Participants: Noninstitutionalized Medicare beneficiaries from various socioeconomic backgrounds, including those receiving Medicaid.

Main outcome measures: Potential OOP cost savings for the upcoming year.

Results: In total, 621 beneficiaries were assisted. Part D plan optimization was performed for 535 beneficiaries; the findings indicated that 435 (81%) could save money (average: $1,334) by switching plans in the upcoming year. The results also demonstrated that 28 beneficiaries could save money (mean: $1,274) through a patient assistance program. In total, 16 beneficiaries had self-reported income and/or assets that were low enough to qualify for additional governmental assistance through the low-income subsidy. Finally, less costly therapeutic alternatives were identified for 7 beneficiaries and prescribers accepted recommendations for change in 6 (85%) such cases. In total, beneficiaries could realize more than $770,000 in potential OOP savings from the performed interventions.

Conclusion: Targeted assistance to beneficiaries through a variety of cost-lowering strategies can help significantly reduce OOP costs and thus may also result in lower cost-related medication nonadherence and improved beneficiary outcomes.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Cost Savings
  • Cross-Sectional Studies
  • Drug Costs*
  • Drug Substitution / economics
  • Eligibility Determination / economics
  • Female
  • Health Expenditures*
  • Health Services Accessibility / economics
  • Humans
  • Income
  • Insurance Benefits / economics*
  • Male
  • Medicare Part D / economics*
  • Medication Therapy Management / economics
  • Middle Aged
  • Prescription Drugs / economics*
  • United States

Substances

  • Prescription Drugs